Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $149.8000 (-1.11%) ($149.6000 - $155.5100) on Fri. Nov. 23, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.91% (three month average) | RSI | 37 | Latest Price | $149.8000(-1.11%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.3% a day on average for past five trading days. | Weekly Trend | LGND declines -4.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(57%) XBI(56%) IWC(54%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.455% in a week (0% probabilities). TLT(-16%) VXX(-15%) VIXM(-11%) UUP(-9%) GDXJ(-7%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.455% (StdDev 2.91%) | Hourly BBV | 0 () | Intraday Trend | 0.1% | | | |
|
1 - 5 Day Possible Target | $142.56(-4.83%) | Resistance Level | $158.42 | 5 Day Moving Average | $150.63(-0.55%) | 10 Day Moving Average | $151.42(-1.07%) | 20 Day Moving Average | $158.42(-5.44%) | To recent high | -45.4% | To recent low | 1.4% | Market Cap | $2.407b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |